Articles

Find an Article

Filter articles

Showing 51 to 60 of 652 results

Medtech M&A: integration is key

US04-09-2018

As the tide of M&A activity continues to rise across the life sciences industry, LSIPR speaks to Tracy MacNeal of Ximedica on what’s driving the trend and the pitfalls to be aware of.

LSIPR 50 2018: Stephen Knight

US04-09-2018

Stephen Knight was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

LSIPR 50 2018: Kush Parmar

US03-09-2018

Kush Parmar was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

Two new weapons for defending Hatch-Waxman litigation

US03-09-2018Mark Remus

Mark Remus of Brinks Gilson & Lione discusses two patent-related challenges for generic pharmaceutical companies and how they might be overcome.

LSIPR 50 2018: Christopher Viehbacher

US31-08-2018

Christopher Viehbacher was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

LSIPR 50 2018: Iana Dimkova

US30-08-2018

Iana Dimkova was selected in the LSIPR 50 2018 publication for​ ​her influence on the life sciences industry. She featured in the investment section, as LSIPR reports.

LSIPR 50 2018: Jean-François Formela

29-08-2018

Jean-François Formela was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

LSIPR 50 2018: Frank Kalkbrenner

Germany28-08-2018

Frank Kalkbrenner was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

LSIPR 50 2018: Bryan Roberts

US27-08-2018

Bryan Roberts was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

LSIPR 50 2018: Jim Tananbaum

US24-08-2018

Jim Tananbaum was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

Showing 51 to 60 of 652 results

LSIPR